DaVita Inc. (NYSE:DVA ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Javier J. Rodriguez - CEO & Executive Director Joel Ackerman - CFO & Treasurer Nic Eliason - Group Vice President of Investor Relations Conference Call Participants Albert J.
DaVita HealthCare (DVA) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.7 per share. This compares to earnings of $2.59 per share a year ago.
DaVita HealthCare (DVA) closed the most recent trading day at $140.37, moving 2.91% from the previous trading session.
DaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
DaVita HealthCare (DVA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DaVita HealthCare (DVA) concluded the recent trading session at $141.84, signifying a -1.36% move from its prior day's close.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $146.71, denoting a +2.99% move from the preceding trading day.
DaVita HealthCare (DVA) reached $137.84 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.